News

The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility treatment.
Mesenchymal precursor cells plus hyaluronic acid significantly reduced chronic low back pain due to degenerative disc disease.
Levothyroxine therapy was associated with improved cardiovascular health but reduced bone health among older adults with subclinical hypothyroidism.
Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online.
Roughly 1 in 10 US internal medicine physicians report a high degree of burnout, according to a study published online.
HealthDay News — The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and ...
Higher BMI was linked to lower cardiovascular risks among ACPA-negative patients with rheumatoid arthritis who use biologic disease-modifying antirheumatic drugs. Body mass index (BMI) is associated ...
Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.
Patients with giant cell arteritis have a greater risk for aortic complications than those with polymyalgia rheumatica.
The FDA has approved Selarsdi (ustekinumab-aken) as interchangeable to the reference product Stelara (ustekinumab).
Immunological tests can differentiate proliferative from non-proliferative lupus nephritis, but anti-C1q antibodies and urinary erythrocytes have the best predictive power to dist ...